Cost analysis of radical resection of malignant breast tumors under the China Healthcare Security Diagnosis Related Groups payment system

Author:

Hu Yun-He,Li Ai-Dong

Abstract

BACKGROUND Breast cancer is one of the most common malignant tumors in women worldwide and poses a severe threat to their health. Therefore, this study examined patients who underwent breast cancer surgery, analyzed hospitalization costs and structure, and explored the impact of China Healthcare Security Diagnosis Related Groups (CHS-DRG) management on patient costs. It aimed to provide medical institutions with ways to reduce costs, optimize cost structures, reduce patient burden, and improve service efficiency. AIM To study the CHS-DRG payment system’s impact on breast cancer surgery costs. METHODS Using the CHS-DRG (version 1.1) grouping criteria, 4073 patients, who underwent the radical resection of breast malignant tumors from January to December 2023, were included in the JA29 group; 1028 patients were part of the CHS-DRG payment system, unlike the rest. Through an independent sample t-test, the length of hospital stay as well as total hospitalization, medicine and consumables, medical, nursing, medical technology, and management expenses were compared. Pearson’s correlation coefficient was used to test the cost correlation. RESULTS In terms of hospitalization expenses, patients in the CHS-DRG payment group had lower medical, nursing, and management expenses than those in the diagnosis-related group (DRG) non-payment group. For patients in the DRG payment group, the factors affecting the total hospitalization cost, in descending order of relevance, were medicine and consumable costs, consumable costs, medicine costs, medical costs, medical technology costs, management costs, nursing costs, and length of hospital stay. For patients in the DRG non-payment group, the factors affecting the total hospitalization expenses in descending order of relevance were medicines and consumable expenses, consumable expenses, medical technology expenses, the cost of medicines, medical expenses, nursing expenses, length of hospital stay, and management expenses. CONCLUSION The CHS-DRG system can help control and reduce unnecessary medical expenses by controlling medicine costs, medical consumable costs, and the length of hospital stay while ensuring medical safety.

Publisher

Baishideng Publishing Group Inc.

Reference11 articles.

1. Performance evaluation of medical service for breast cancer patients based on diagnosis related groups

2. National Healthcare Security Administration. Notice on issuing a list of national pilot cities for group payment based on disease diagnosis (YiBao Fa [2019] No. 34). Jun 5, 2019. [cited 24 March 2024]. Available from: http://www.nhsa.gov.cn/art/2019/6/5/art_37_1362.html

3. National Healthcare Security Administration. Notice on issuing the three-year action plan for DRG/DIP payment method reform (YiBao Fa [2021] No. 48). Nov 26, 2021. [cited 24 March 2024]. Available from: http://www.nhsa.gov.cn/art/2021/11/26/art_104_7413.html

4. Beijing Healthcare Security Administration. Notice on Issuing the Management Measures for Excluding Payment for CHS-DRG Paid New Drugs and Technologies (Trial Implementation) (Jing YiBao Zhongxin Fa [2022] No. 30). Jul 13, 2022. [cited 24 March 2024]. Available from: https://ybj.beijing.gov.cn/tzgg2022/202207/t20220713_2798069.html

5. What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3